Journal
CLINICAL CASE REPORTS
Volume 8, Issue 12, Pages 2641-2644Publisher
WILEY
DOI: 10.1002/ccr3.3250
Keywords
chronic myelomonocytic leukemia; eculizumab; warm autoimmune hemolytic anemia
Categories
Ask authors/readers for more resources
Eculizumab may be considered as an emergency therapeutic option in refractory life-threatening warm autoimmune hemolytic anemia especially if direct antiglobulin test is positive for both IgG and C3d and after failure of all conventional treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
